Impact of CYP2D6 polymorphism on plasma levels of donepezil: clinical relevance in patients with Alzheimer’s diseaseM.G. Scordo, Giuseppe Lombardi, Federica Varsaldi et al.|Unknown|2004Cited by 0
Impact of CYP3A4 polymorphisms on donepezil plasma levels and therapeutic outcomeM.G. Scordo, Miriam Dahl, Laura Villa et al.|Unknown|2007Cited by 0
Association between apolipoprotein E polymorphism and Alzheimer disease in Novara, ItalyFederica Varsaldi, Giuseppe Lombardi, Gianluca Miglio et al.|Unknown|2005Cited by 0